German medical packaging maker Gerresheimer is exploring a potential sale amid interest from private equity funds, Bloomberg News reported on Friday, citing people familiar with the matter.
Gerresheimer's shares rose as much as 6.8% on Wednesday after a regulatory filing showed activist investor Ricky Chad Sandler had bought a 5.43% stake in German medical packaging maker.
Gerresheimer AG (OTCPK:GRRMF) Q2 2024 Earnings Conference Call July 11, 2024 4:00 AM ET Company Participants Guido Pickert - IR Dietmar Siemssen - CEO Bernd Metzner - CFO Conference Call Participants Oliver Reinberg - Kepler Cheuvreux Victoria Lambert - Berenberg Oliver Metzger - ODDO Paul Knight - KeyBanc Annapurna Bain - Barclays Olivier Calvet - UBS Klaus Brune - Platow Verlag David Adlington - JPMorgan Edward Hall - Stifel Falko Friedrichs - Deutsche Bank Curtis Moiles - BNP Paribas Alexander Galitsa - Hauck Aufhauser Investment Banking Operator Ladies and gentlemen, welcome to the Gerresheimer AG's Q2 and First Half 2024 Results Conference Call. I am Charley, the Chorus Call operator.
Germany's Gerresheimer posted second-quarter adjusted core profit in line with market expectations on Thursday, driven by the deal pipeline for its plastics and devices segment, which supplies makers of weight-loss drugs with autoinjector pens.